Orexin 2 Receptor Agonist
CAS No. 1796565-52-0
Orexin 2 Receptor Agonist( MDK-5220 | MDK5220. Orexin2 receptor agonist )
Catalog No. M17380 CAS No. 1796565-52-0
Orexin 2 Receptor Agonist is an effective (EC50: 23 nM) and OX2R-selective (OX1R/OX2R EC50 ratio: 70) agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 53 | In Stock |
|
| 5MG | 87 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 209 | In Stock |
|
| 50MG | 368 | In Stock |
|
| 100MG | 536 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOrexin 2 Receptor Agonist
-
NoteResearch use only, not for human use.
-
Brief DescriptionOrexin 2 Receptor Agonist is an effective (EC50: 23 nM) and OX2R-selective (OX1R/OX2R EC50 ratio: 70) agonist.
-
DescriptionMDK-5220 is a potent ans selective Orexin2 receptor agonist. MDK-5220 has CAS#1796565-52-0, which has previously no designed code name. For the convenience of communication, MedKoo temporally names it as MDK-5220 (note: 5220 is the last four digit of its CAS#). MDK-5220 was reported in WO2015088000. MDK-5220 exhibits an orexin agonist activity and is expected to be useful as an excellent therapeutic or preventive agent for narcolepsy.
-
In Vitro——
-
In Vivo——
-
SynonymsMDK-5220 | MDK5220. Orexin2 receptor agonist
-
PathwayCell Cycle/DNA Damage
-
TargetROCK
-
RecptorO2XR
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1796565-52-0
-
Formula Weight586.7
-
Molecular FormulaC32H34N4O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 32 mg/mL; 54.54 mM
-
SMILESc1(cccc(c1)C(=O)N(C)C)c1ccc(c(c1)S(=O)(=O)Nc1cccc(c1)NCCNC(=O)c1cc(ccc1)C)OC
-
Chemical Name4'-methoxy-N,N-dimethyl-3'-(N-(3-((2-(3-methylbenzamido)ethyl)amino)phenyl)sulfamoyl)-[1,1'-biphenyl]-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nagahara T, et al. J Med Chem. 2015 Oct 22;58(20):7931-7.
molnova catalog
related products
-
Cotosudil
Cotosudil is a ROCK kinase inhibitor with antihypertensive activity and is used to treat or prevent diseases or conditions caused by cataracts, cardiovascular or neurodegenerative diseases or nerve damage.
-
BDP9066
BDP9066 is a potent and selective MRCK inhibitor that inhibits MRCKβ and MRCKα/β and can be used for the prevention and treatment of skin cancer.
-
CID-5056270
CID-5056270 has anticancer activity and can inhibit lung cancer, anal cancer, bladder cancer, cervical cancer, vulvar cancer, penile cancer, Burkitt's lymphoma, breast cancer and bone cancer.
Cart
sales@molnova.com